Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media, as well as to allow video information to be shared for both marketing, analytics and editorial purposes.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content
Fig. 2 | Biological Research

Fig. 2

From: Regional Hereditary Cancer Program in Chile: A scalable model of genetic counseling and molecular diagnosis to improve clinical outcomes for patients with hereditary cancer across Latin America

Fig. 2

Genealogy of the families of patients with germline pathogenic variants. The age of cancer diagnosis is reported for each individual, the arrow indicates the proband of each family, * indicates family members who were evaluated for the pathogenic mutation. The pathogenic variants were confirmed by Sanger (gray in electropherograms), all identified in a heterozygous state. The age of cancer diagnosis (AAD)

Back to article page

Biological Research

ISSN: 0717-6287

Contact us